Synopsys Beats Q1 EPS, Reiterates FY26 Guidance, and Authorizes $2 Billion Stock Repurchase
summarizeSummary
Synopsys announced better-than-expected Q1 non-GAAP EPS and revenue at the high end of guidance, while reiterating full-year targets and authorizing a significant $2 billion stock repurchase program.
check_boxKey Events
-
Q1 FY26 Financial Results Exceed Expectations
Synopsys reported first-quarter fiscal year 2026 revenue of $2.409 billion, reaching the high end of its prior guidance. Non-GAAP earnings per diluted share (EPS) of $3.77 surpassed prior guidance, demonstrating strong operational performance.
-
Full-Year FY26 Guidance Reiterated
The company reiterated its expectations for full-year fiscal year 2026 total revenue of $9.61 billion at the midpoint, including $2.9 billion of expected Ansys revenue, and non-GAAP EPS guidance of $14.38 to $14.46.
-
$2 Billion Stock Repurchase Program Authorized
The board of directors approved a replenishment of the existing stock repurchase program, authorizing the purchase of up to an additional $2 billion of Synopsys common stock. This represents a significant capital return initiative.
auto_awesomeAnalysis
Synopsys reported strong first-quarter fiscal year 2026 results, exceeding non-GAAP EPS guidance and achieving revenue at the high end of its range. The company also reiterated its full-year fiscal 2026 financial targets, signaling confidence in its ongoing performance. Further bolstering investor sentiment, the board authorized a substantial $2 billion replenishment of its stock repurchase program, demonstrating a commitment to returning capital to shareholders and indicating management's positive outlook on the company's valuation.
At the time of this filing, SNPS was trading at $440.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $85.9B. The 52-week trading range was $365.74 to $651.73. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.